Revenue

Newcomer Capital-FORCE makes a strategic entry into the competitive ETF space by acquiring two established IBD-branded funds from Innovator.

Dynamite Wallet wants to make your face your private key. This leap in usability could ignite mass adoption, but it also raises critical security questions.

Nested Therapeutics' NST-628 reports a 38% response rate in advanced melanoma, offering new hope with a novel, brain-penetrating cancer-fighting agent.

The massive new Woodstock facility aims to redefine the travel experience for truckers and motorists with extensive amenities and a new rewards program.

An innovative green financing deal is building a new retail destination in Houston, promising huge energy savings and a new model for urban development.

Interim study results suggest a common food product may significantly enhance the effectiveness of modern cancer treatments, heralding a new era of care.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.

An appeals court strikes down a Los Angeles ordinance on relocation fees but upholds eviction rules, reshaping the legal landscape for landlords and tenants.

New guidelines advise biennial screening for women 50-74 and caution for others, a move that has drawn sharp criticism from other medical bodies.

Celebrating 10 years, Tampa's Global Widget has become a manufacturing titan by capitalizing on the multi-billion dollar gummy supplement boom.

Singapore's aquatic education leader prices a complex public offering to fuel a pivot into new sports, facing investor scrutiny and a volatile stock history.

Six years after Hurricane Laura, Lake Charles opens a world-class Mardi Gras museum, signaling a new era of cultural tourism and resilience.

The $4.1 trillion U.S. Latino economy is being leveraged to tackle energy costs, infrastructure challenges, and the soaring demands of AI technology.

The specialty materials leader affirmed its quarterly dividend, reflecting strong financial health and a strategic position in high-demand global markets.

For the first time, a major regulatory body has approved a drug name created by AI, signaling a new era for the highly regulated pharmaceutical industry.

The era of monolithic chips is ending. A new wave of system-level design using advanced packaging is solving AI's biggest power and bandwidth challenges.

Challenging Apple and Google, a new smartphone debuts in Japan that ditches the app grid for an AI-native OS built on a decade of research.

Vaxart's new $25M financing deal provides a crucial cash runway, but is it a savvy strategic move or a necessary step to stay in the race?

A new partnership between Wilcrest Pharma and healthcare giant Premier, Inc. aims to streamline hazardous drug compounding for thousands of U.S. hospitals.

As the Boston Marathon marks its 130th run, Boston Globe Media celebrates a parallel legacy with its most ambitious, multi-platform coverage strategy yet.